Dyne Therapeutics, Inc. Common Stock DYN
$20.31
-16.35%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-519,406,000
- Net Margin
- —
- Return on Equity
- -73.97%
- Debt-to-Equity
- 0.28
- P/E Ratio
- —
- Price / Book
- 5.40
- Price / Sales
- —
Over the trailing twelve months, Dyne Therapeutics, Inc. Common Stock generated revenue of — and net income of $-519,406,000.
Key Stats
- Last Close
- $20.31
- Market Cap
- $3.79 billion
- 52-Week Range
- $9.89 – $27.30
- Average Volume
- 2.32 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.